COVID-19
Novel coronavirus pneumonia (NCP) or SARS-COV-2, officially named "coronavirus disease 2019" (COVID-19) by the World Health Organization, is a respiratory infection caused by a new virus first identified in late 2019.
- Product name
- Catalog NO.
- Source
- Usage
- Platform
- Anti SARS-COV-2 Nucleocapsid(NP) mAb ABCOVN02
- Catalog NO. ABCOVN02
- Source Mouse
- Usage Coating
- Platform GICA, FIA, ELISA
- Anti SARS-COV-2 Nucleocapsid(NP) mAb ABCOVN01
- Catalog NO. ABCOVN01
- Source Mouse
- Usage Labeling
- Platform GICA, FIA, ELISA
- Anti SARS-COV-2 Nucleocapsid(NP) mAb ABCOVN05
- Catalog NO. ABCOVN05
- Source HEK293
- Usage Coating
- Platform GICA, FIA, ELISA
- SARS-COV-2 Spike RBD Recombinant Protein-HRP HRCOVS01
- Catalog NO. HRCOVS01
- Source HEK293
- Usage Labeling
- Platform ELISA
- Human ACE2-hFc Recombinant Protein AGACE202
- Catalog NO. AGACE202
- Source HEK293
- Usage Coating
- Platform GICA, FIA, CLIA, ELISA
- Human ACE2 Recombinant Protein AGACE201
- Catalog NO. AGACE201
- Source HEK293
- Usage Coating
- Platform GICA, FIA, CLIA, ELISA
- Anti SARS-COV-2 Nucleocapsid(NP) mAb ABCOVN10
- Catalog NO. ABCOVN10
- Source Mouse
- Usage Labeling
- Platform GICA, FIA, ELISA
- Anti SARS-COV-2 Nucleocapsid(NP) mAb ABCOVN11
- Catalog NO. ABCOVN11
- Source Mouse
- Usage Coating
- Platform GICA, FIA, ELISA
- SARS-CoV-2 Spike RBD IgG Humanized mAb AGCOVS06
- Catalog NO. AGCOVS06
- Source HEK293
- Usage Calibrators
- Platform GICA, FIA, ELISA
- Anti SARS-COV-2 Spike RBD mAb ABCOV015
- Catalog NO. ABCOV015
- Source Mouse
- Usage Coating
- Platform GICA, FIA
- Anti SARS-COV-2 Spike RBD mAb ABCOVS03
- Catalog NO. ABCOVS03
- Source Mouse
- Usage Coating
- Platform GICA, FIA
- Anti SARS-COV-2 Spike RBD mAb ABCOVS01
- Catalog NO. ABCOVS01
- Source Mouse
- Usage Labeling
- Platform GICA, FIA
- Anti SARS-COV-2 Spike RBD mAb ABCOVS02
- Catalog NO. ABCOVS02
- Source Mouse
- Usage Labeling
- Platform GICA, FIA
- Anti SARS-COV-2 Neutralizing Antibody CTCOV003
- Catalog NO. CTCOV003
- Source Mouse
- Usage Calibrators
- Platform GICA, FIA, ELISA
- SARS-COV-2 Nucleocapsid Recombinant Protein AGCOVN01
- Catalog NO. AGCOVN01
- Source E.coli
- Usage Labeling
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 Spike RBD-mFc Recombinant Protein AGCOVS03
- Catalog NO. AGCOVS03
- Source HEK293
- Usage Coating
- Platform GICA, FIA, ELISA
- SARS-COV-2 Spike RBD Recombinant Protein AGCOVS01
- Catalog NO. AGCOVS01
- Source HEK293
- Usage Labeling
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 Spike RBD Recombinant Protein AGCOVS02
- Catalog NO. AGCOVS02
- Source HEK293
- Usage Labeling
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 S1 Recombinant Protein (high purity) AGCOVS05
- Catalog NO. AGCOVS05
- Source HEK293
- Usage
- Platform GICA, FIA, CLIA, ELISA
- SARS-COV-2 S1 Recombinant Protein AGCOVS04
- Catalog NO. AGCOVS04
- Source HEK293
- Usage
- Platform GICA, FIA, CLIA, ELISA
Shenzhen AIVD Biotechnology Co. , LTD.
A4 Building 4th Floor / B5 Building C501, China Merchants Bright Technology Park, Fenghuang Street, Guangming District, Shenzhen, Guangdong Province, China
E-mail:
market@aivdbiotech.com
info@aivdbiotech.com
Tel: +86-755-26165742 +86 18543132823
WhatsApp:+86 18543132823
© 2022 Shenzhen AIVD Biotechnology Co.,LTD. 粤ICP备18093805号